Skip to main content
. Author manuscript; available in PMC: 2017 Jul 13.
Published in final edited form as: Front Biosci (Landmark Ed). 2017 Jan 1;22:558–569. doi: 10.2741/4502

Figure 5.

Figure 5

Effects of proteasome or MMP inhibition on proteasome and collagen I levels in CAMs. Treatment of CAMs with MG132, a specific, potent proteasome inhibitor (A-C) and MMP inhibitor, Bat (D-F) did not change the collagen I content in vehicle or TGF-β stimulated CAMs. Shown are representative Western blot gels (A and D) and the data from densitometric analysis (B, C, E, F) (n=4). * P<0.0.5 compared to vehicle-treated samples.